Cerebrospinal Fluid Management: An Emerging Market with Attractive Growth Opportunities
According to the new market research “Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) – Global Forecast to 2022″, analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global cerebrospinal fluid management market was valued at USD 1.20 Billion in 2016 and is projected to reach USD 1.56 Billion by 2022, at a CAGR of 4.4%.
The global Cerebrospinal Fluid Management market is segmented based on product, end user and regions.
By product, the cerebrospinal fluid (CSF) management market is segmented into shunts and external drainage systems. In 2017, the shunts segment accounted for the largest share of the global market. The large share of this segment can be primarily attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries owing to shunt malfunction and infection.
Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575
Browse and in-depth TOC on in “Cerebrospinal Fluid Management Market ”
92 – Tables
31 – Figures
120 – Pages
On the basis of end user, the cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. In 2017, the pediatric segment held the largest share of the global market. The large share of this segment can be primarily attributed to high prevalence of congenital hydrocephalus along with the rising number of shunting procedures in the pediatric population.
Request Free Sample Report @
In 2017, North America held the largest share of the cerebrospinal fluid (CSF) management market, followed by Europe. Factors such as the rising prevalence of hydrocephalus, increasing funding for hydrocephalus research in the US, and the launch of Hydrocephalus Canada are contributing to the dominant share of this region.
The key players in the Cerebrospinal Fluid Management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
View Complete Press Release @